BSX
$99.22
Revenue | $5061Mn |
Net Profits | $793Mn |
Net Profit Margins | 15.67% |
Boston Scientific Corp.’s revenue jumped 22.84% since last year same period to $5061Mn in the Q2 2025. On a quarterly growth basis, Boston Scientific Corp. has generated 8.54% jump in its revenue since last 3-months.
Boston Scientific Corp.’s net profit jumped 144.75% since last year same period to $793Mn in the Q2 2025. On a quarterly growth basis, Boston Scientific Corp. has generated 17.66% jump in its net profits since last 3-months.
Boston Scientific Corp.’s net profit margin jumped 99.25% since last year same period to 15.67% in the Q2 2025. On a quarterly growth basis, Boston Scientific Corp. has generated 8.4% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.71 |
EPS Estimate Current Year | 0.71 |
Boston Scientific Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.71 - a -2.74% fall from last quarter’s estimates.
Boston Scientific Corp.’s earning per share (EPS) estimates for the current year stand at 0.71.
Earning Per Share (EPS) | 0 |
Boston Scientific Corp.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Boston Scientific Corp. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-08-01 | 0.73 | 0.75 | 2.74% |
2025-05-01 | 0.67 | 0.75 | 11.94% |
2025-10-22 | 0.71 | 0 | -100% |